Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignanciesAnne Knisely, Aung Naing, Daniel D. Karp et al.|Cancer|2023Cited by 17
Safety and efficacy of HLA-G–targeted CAR T cells (IVS-3001) in patients with advanced HLA-G–positive solid tumors: Clinical trial in progress.Samer A. Srour, Aung Naing, Nizar M. Tannir et al.|Journal of Clinical Oncology|2025Cited by 2